Neurogene's Gene Replacement Program is the Eighth Biopharmaceutical Company Program Facilitated by the Rett Syndrome Research Trust
Trumbull, CT (PRWEB) May 19, 2022 -- The research and resource development efforts of the Rett Syndrome Research Trust (RSRT) have helped generate an eighth
Source: prweb.com